GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · BSE Equity Only

BSE Exchange Filings, Explained Simply

AI-powered plain-English analysis of every important BSE announcement — financial results, order wins, dividends, mergers and more. Updated live.

Today
Total
BSE
Exchange
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings

📋 Filing Types Available on ForgeUp Filings Strictly sourced from BSE exchange announcements (equity segment only). We show only material, important filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India exchange announcements. More categories will be added over time.
Neogen Chemicals Ltd
Earnings presentation on unaudited results for Q1FY2027.
RESULTS ▲ Positive Development MEDIUM RISK
📅 Filed on BSE: 26 Jul 2026, 04:54 PM IST  ·  BSE ID: 18d04433-772b-4e63-b696-6cb501a01252
View Original BSE Filing (PDF)
💡
In Simple Terms
Neogen Chemicals reported higher profits and sales for Q1 FY27, completed rebuilding a key plant, and plans to raise INR 600 crore.
🤖 AI Summary
  • Neogen Chemicals reported Q1 FY27 consolidated Profit After Tax (PAT) of INR 17.1 crore, a 67% increase year-over-year.
  • Consolidated revenue for Q1 FY27 stood at INR 250.3 crore, marking a 34% growth compared to Q1 FY26.
  • Standalone Profit After Tax (PAT) for Q1 FY27 was INR 19.4 crore, up 37% from INR 14.2 crore in Q1 FY26.
  • The Dahej plant reconstruction is complete, with trial runs initiated and commercial production commencing soon.
  • The Board approved raising up to INR 600 Crore through a Qualified Institutional Placement (QIP) of eligible securities.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Consolidated Revenue (Q1 FY27)
INR 250.3 crore
34%
Consolidated Profit After Tax (Q1 FY27)
INR 17.1 crore
67%
Standalone Revenue (Q1 FY27)
INR 252.3 crore
37%
Standalone Profit After Tax (Q1 FY27)
INR 19.4 crore
37%
Approved Fundraise
INR 600 Crore
🏢 How This Affects the Company
📈
Business Impact
The operational Dahej plant, after reconstruction, will contribute to production capacity and volume growth, supported by new capacities in Battery Chemicals and Organolithium. Revenue expansion is anchored by higher volumes for key product lines, including a robust Organolithium portfolio.
💰
Financial Impact
Consolidated Revenue grew 34% to INR 250.3 crore, and Consolidated PAT increased by 67% to INR 17.1 crore. Higher interest expenses, up 64% YoY, are attributed to increased debt drawdown for CAPEX and working capital intensity. The INR 600 crore fundraise will provide capital for expansion initiatives.
⚙️
Operational Impact
Reconstruction of the Dahej plant is complete, with trial runs underway, indicating a return to full operational capacity. Neogen Ionics' Dahej Phase 1 and Pakhajan Phase 2 Battery Materials projects are on schedule for completion by February and March 2027 respectively, with mechanical assembly and trial runs initiated for Electrolytes.
⚠️
Risk Impact
Cumulative insurance recoveries for the Dahej fire incident total INR 164 crore, reducing the net claim receivable to INR 186 crore and mitigating financial exposure. Higher finance costs due to debt for CAPEX and working capital present a financial management challenge.
👥 What This Means For Shareholders
Action Required
Shareholders are not required to take immediate action based on this earnings presentation.
👤
Who Is Affected
Existing shareholders will be affected by potential dilution from the Qualified Institutional Placement (QIP) as new shares are issued. The fundraise aims to support growth initiatives benefiting all shareholders long-term.
🔍
Management Signal
Management is focused on significant growth through strategic CAPEX, expansion in Battery Chemicals, and strengthening the financial position by raising substantial capital.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Announcement of QIP launch and allocation details for the INR 600 crore fundraise.
Official commencement of commercial production at the reconstructed Dahej plant.
Updates on Neogen Ionics' Battery Materials projects completion and commercial supplies.
MEDIUM RISK High interest burden from debt drawdown and outstanding insurance claims introduce financial risks.
💡 Investor Takeaway
Neogen Chemicals reported Q1 FY27 consolidated revenue of INR 250.3 crore, up 34% YoY, and consolidated PAT of INR 17.1 crore, up 67% YoY. The Dahej plant reconstruction is complete with trial runs, and the Board approved an INR 600 crore fundraise via QIP, signaling expansion focus.
⚖️ Strengths & Concerns

✅ Positives

  • Consolidated Profit After Tax increased by 67% to INR 17.1 crore in Q1 FY27, reflecting strong underlying operating trends.
  • Consolidated Revenue grew 34% to INR 250.3 crore, bolstered by higher volumes across key product lines and the Organolithium portfolio.

⚠️ Concerns

  • Consolidated Interest expenses increased by 64% to INR 20.8 crore in Q1 FY27, driven by higher debt for CAPEX and working capital.
  • The net claim receivable for the Dahej fire incident stands at INR 186 crore on a consolidated basis, indicating outstanding recovery.
📅 Company Track Record
Neogen Chemicals Ltd. reported a Q1 FY27 net profit of Rs. 19.44 Crore and approved a Rs. 600 Crore fundraise in a prior filing on July 24, 2026. The Board also met on May 16, 2026, to consider FY26 results and dividends.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Neogen Chemicals' consolidated net profit for Q1 FY27?
Neogen Chemicals reported a consolidated Profit After Tax (PAT) of INR 17.1 crore for Q1 FY27, representing a 67% increase compared to Q1 FY26.
What was Neogen Chemicals' consolidated revenue in Q1 FY27?
The consolidated revenue for Neogen Chemicals in Q1 FY27 was INR 250.3 crore, marking a 34% growth over Q1 FY26.
What is the status of the Dahej plant reconstruction?
The reconstruction of the Dahej plant is complete, with trial runs currently underway. Commercial production is scheduled to begin soon.
How much capital did Neogen Chemicals' Board approve to raise?
The Board of Directors approved raising up to INR 600 Crore through the issuance of eligible securities via a Qualified Institutional Placement (QIP).
What was the revenue of Neogen Ionics (NIL) in Q1 FY27?
Neogen Ionics (NIL) generated revenue of INR 19 crore in Q1 FY27, compared to INR 5 crore in Q1 FY26.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.